Literature DB >> 12003426

Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol.

Anna M Buchner1, Amnon Sonnenberg.   

Abstract

OBJECTIVE: The Patient Treatment File of the Department of Veterans Affairs comprises the computerized records of all inpatients treated in all Veterans Affairs hospitals distributed throughout the United States. This database was used to study the association between liver disease and clinically manifest cholelithiasis.
METHODS: The computerized medical records of 38,459 patients with various forms of liver disease and 69,336 controls without the diagnosis were extracted from the annual files between 1990 and 1993. In a multiple logistic regression analysis, the occurrence of cholelithiasis served as the outcome variable, whereas different forms of liver disease and demographic characteristics, such as age, gender, and ethnicity, served as predictor variables.
RESULTS: Among the control population, cholelithiasis was reported in 5.2% (3,571 of 69,336) of subjects. Cholelithiasis occurred in 7.5% (2,898 of 38,459) of patients with all liver disease, 9.5% (1,642 of 17,287) of patients with alcoholic liver cirrhosis, 13.7% (981 of 7,149) of patients with nonalcoholic liver cirrhosis, and 9.1% (66 of 728) of patients with alcoholic fatty liver (chi2 = 1059, df = 4, p < 0.001). In the logistic regression, the odds ratios (ORs) for cholelithiasis associated with various forms of liver disease were: in all liver diseases combined (OR = 1.31, 95% CI = 1.25-1.38), in alcoholic liver cirrhosis (OR = 1.62, 95% CI = 1.54-1.72), in nonalcoholic liver cirrhosis (OR = 2.07, 95% CI = 1.94-2.21), and in alcoholic fatty liver (OR = 1.40, 95% CI = 1.11-1.75). Other risk factors for cholelithiasis besides liver disease were: female gender (OR = 1.43, 95% CI = 1.25-1.63), older age (OR = 1.28 per age decade, 95% CI = 1.26-1.30), Native American (OR = 1.38, 95% CI = 1.12-1.72) or Hispanic ethnicity (OR = 1.25, 95% CI = 1.15-1.35), and presence of diabetes mellitus (OR = 1.43, 95% CI = 1.35-1.52). A history of alcoholism exerted a protective influence (OR = 0.92, 95% CI = 0.87-0.97).
CONCLUSION: Gallstone disease occurs frequently in hospitalized patients with chronic liver disease or liver cirrhosis and contributes to the burden of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12003426     DOI: 10.1111/j.1572-0241.2002.05607.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

Review 1.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

Review 2.  Gallstone Disease in Cirrhosis-Pathogenesis and Management.

Authors:  Bipadabhanjan Mallick; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2021-09-16

3.  Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease.

Authors:  Man-Chen Hung; Chuen-Fei Chen; Meng-Ting Tsou; Hsin-Hui Lin; Lee-Ching Hwang; Ching-Ping Hsu
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-09       Impact factor: 3.168

4.  Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.

Authors:  Phui-Ly Liew; Wei-Jei Lee; Weu Wang; Yi-Chih Lee; Wei-Yu Chen; Chia-Lang Fang; Ming-Te Huang
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

5.  Helicobacter pylori infection is associated with gallstones: Epidemiological survey in China.

Authors:  Fen-Ming Zhang; Chao-Hui Yu; Hong-Tan Chen; Zhe Shen; Feng-Ling Hu; Xiao-Ping Yuan; Guo-Qiang Xu
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

Review 6.  Laparoscopic cholecystectomy in cirrhotics.

Authors:  Norman Oneil Machado
Journal:  JSLS       Date:  2012 Jul-Sep       Impact factor: 2.172

7.  Frequency of gallstones and mean BMI in decompensated cirrhosis.

Authors:  Ayesha Aslam Rai; Aisha Nazeer; Nasir Hassan Luck
Journal:  Pan Afr Med J       Date:  2018-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.